Feryal Clark

I thank my hon. Friend the Member for North Ayrshire and Arran (Irene Campbell) for opening this important debate, and I thank all hon. Members for their contributions. We appreciate that the use of animals in medical research stirs the strong emotional instincts of many people across the UK, including many colleagues here. The day when we can finally bring an end to animal testing cannot come soon enough. Sadly, however, that day is not here yet. Phasing out animal testing has to be done in lockstep with the development of safe, accurate and validated alternatives. The reality is that the technology is not yet advanced enough for alternative methods to completely replace the use of animals. Consequently, the carefully regulated use of animals remains necessary to protect humans and the wider environment. Animal testing continues to be required by international agreements, which all global medicines regulators follow, including the UK’s Medicines and Healthcare products Regulatory Agency. Such testing is regulated through the Animals (Scientific Procedures) Act 1986, known as ASPA. The Act specifies that animals can only be used in science for specific, limited purposes where there are no alternatives, where the number of animals used is the minimum needed to achieve the scientific benefit, and where the potential harm to the animals is limited to the absolute minimum. This is known as the three Rs: replacement, reduction and refinement. The system also includes a three-tier system of licensing that licenses each establishment, project and individual involved in performing regulated procedures involving animals. New technologies including AI, as referred to by colleagues, do offer potentially revolutionary ways to create alternative technologies. That is why our manifesto commits us to partnering with scientists, industry and civil society as we work towards the phasing out of animal testing. As the first step, we will publish a strategy later this year laying out how the Government will support the development, validation and uptake of alternative methods, and officials are working on this as we speak. The strategy will set out how we will create a research and innovation system that replaces animals with alternative methods wherever possible and that places the UK at the forefront of international efforts to drive this agenda. I am proud to say that the UK is already world-leading in the development of alternative methods, and we are keen to utilise this technology as much as possible.